ARA290

Description

Buy ARA290 2mg New Zealand

This product is intended for research purposes only. To be used by trained professionals only.

ARA290 is a small peptide derived from the erythropoietin helix beta domain (EPO). EPO has long been known to have effects other than stimulating the production of red blood cells in the bone marrow.

In diabetic neuropathy, the glycoprotein, a protein made in the kidney, has been shown to stimulate blood vessel growth, promote cell survival, and alter blood pressure.

As an EPO neuroprotectant and pain reliever, ARA-290 does not stimulate the production of red blood cells.

For diabetes and autoimmunity, ARA-290 could be tested, according to New Zealand studies [1]. In addition, the peptide’s ability to alleviate neuropathic pain is currently being studied [2].

It is also being studied as a possible wound-healing stimulant, an immune-modulator, and potential systemic lupus erythematosus (lupus or SLE) treatment.

References:

[1] https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3883966/

[2] https://molmed.biomedcentral.com/ articles/10.2119/molmed.2012. 00332

Molecular Formula: C51H84N16O21

Sequence: XEQLERALNSS

Storage: Lyophilized peptides stored below -18°C.

Research use only. Not for human or animal consumption!

ALL CONTENT AND PRODUCT INFORMATION AVAILABLE ON THIS WEBSITE IS FOR EDUCATIONAL PURPOSES ONLY.

DISCLAIMER: These products are intended solely as a research chemical only. This classification allows for their use only for research development and laboratory studies. The information available on our New Zealand Direct Peptides website: https://new-zealand.direct-peptides.com is provided for educational purposes only. These products are not for human or animal use or consumption in any manner. Handling of these products should be limited to suitably qualified professionals. They are not to be classified as a drug, food, cosmetic, or medicinal product and must not be mislabelled or used as such.

Buy ARA290 Online From New Zealand Direct Peptides